3.60
price up icon5.88%   0.20
after-market Dopo l'orario di chiusura: 3.61 0.010 +0.28%
loading
Precedente Chiudi:
$3.40
Aprire:
$3.37
Volume 24 ore:
380.94K
Relative Volume:
0.93
Capitalizzazione di mercato:
$189.94M
Reddito:
-
Utile/perdita netta:
$-197.68M
Rapporto P/E:
-0.9574
EPS:
-3.76
Flusso di cassa netto:
$-158.88M
1 W Prestazione:
+4.65%
1M Prestazione:
-25.00%
6M Prestazione:
-51.55%
1 anno Prestazione:
+13.21%
Intervallo 1D:
Value
$3.26
$3.635
Intervallo di 1 settimana:
Value
$3.26
$3.8069
Portata 52W:
Value
$1.92
$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
Nome
Kodiak Sciences Inc
Name
Telefono
650-281-0850
Name
Indirizzo
1200 PAGE MILL RD, PALO ALTO, CA
Name
Dipendente
113
Name
Cinguettio
@kodiaksciences
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
KOD's Discussions on Twitter

Confronta KOD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KOD
Kodiak Sciences Inc
3.60 188.89M 0 -197.68M -158.88M -3.76
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-09 Aggiornamento Jefferies Hold → Buy
2024-09-05 Iniziato H.C. Wainwright Neutral
2023-12-11 Ripresa Goldman Sell
2023-11-17 Aggiornamento CapitalOne Equal Weight → Overweight
2023-07-27 Downgrade UBS Buy → Neutral
2023-07-25 Downgrade Chardan Capital Markets Buy → Neutral
2023-07-25 Downgrade JP Morgan Neutral → Underweight
2023-07-24 Downgrade CapitalOne Overweight → Equal Weight
2023-07-24 Downgrade Jefferies Buy → Hold
2022-11-15 Iniziato CapitalOne Overweight
2022-08-02 Downgrade Citigroup Neutral → Sell
2022-02-24 Downgrade JP Morgan Overweight → Neutral
2022-02-11 Iniziato Goldman Buy
2022-02-02 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento ROTH Capital Neutral → Buy
2021-03-12 Iniziato Evercore ISI Outperform
2021-03-01 Downgrade Barclays Equal Weight → Underweight
2021-02-17 Downgrade ROTH Capital Buy → Neutral
2021-01-25 Downgrade BMO Capital Markets Outperform → Market Perform
2020-12-17 Iniziato Berenberg Buy
2020-12-16 Iniziato UBS Buy
2020-12-11 Iniziato Citigroup Neutral
2020-11-30 Downgrade JP Morgan Overweight → Neutral
2020-11-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-11-13 Downgrade Goldman Buy → Neutral
2020-03-31 Iniziato BMO Capital Markets Outperform
2020-03-03 Iniziato Goldman Buy
2020-02-18 Downgrade Barclays Overweight → Equal Weight
2020-02-06 Iniziato SunTrust Buy
2020-01-08 Iniziato ROTH Capital Buy
2020-01-03 Iniziato Jefferies Buy
2019-12-24 Iniziato JP Morgan Overweight
2019-10-15 Reiterato Chardan Capital Markets Buy
2019-02-20 Iniziato Chardan Capital Markets Buy
2018-10-29 Iniziato Barclays Overweight
2018-10-29 Iniziato BofA/Merrill Buy
2018-10-29 Iniziato Morgan Stanley Overweight
Mostra tutto

Kodiak Sciences Inc Borsa (KOD) Ultime notizie

pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare C - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences Reveals Latest Retinal Disease Breakthroughs at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads - Investing.com Australia

May 28, 2025
pulisher
May 27, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads By Investing.com - Investing.com India

May 27, 2025
pulisher
May 25, 2025

Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus - The Globe and Mail

May 25, 2025
pulisher
May 19, 2025

Kodal Minerals Nears Export Permit For Mali Lithium Project - Finimize

May 19, 2025
pulisher
May 15, 2025

Kodiak Sciences Inc Reports Q1 2025 Earnings: EPS of -$1.09 Misses Estimates, No Revenue Reported - GuruFocus

May 15, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress - GuruFocus

May 14, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress | KOD Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Announces Recent Business Highlights and First Q - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Reports Deeper Q1 Loss: What 3 Key Phase 3 Trials Mean for Future Growth - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences (KOD) Projected to Post Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 13, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Makes New $209,000 Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - The AM Reporter

May 09, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Invests $209,000 in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 09, 2025

Wells Fargo & Company MN Sells 2,710 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 07, 2025

Ratio Review: Analyzing Kodiak Sciences Inc (KOD)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025
pulisher
May 07, 2025

Retinal vein occlusion Market: Epidemiology, Therapies, - openPR.com

May 07, 2025
pulisher
May 06, 2025

BlackRock, Inc. Reduces Stake in Kodiak Sciences Inc. - GuruFocus

May 06, 2025
pulisher
May 02, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatilit - GuruFocus

May 02, 2025
pulisher
May 02, 2025

CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics - The Malaysian Reserve

May 02, 2025
pulisher
May 01, 2025

Breakthrough Eye Disease Platform: Kodiak Sciences Reveals 7 Major Advances at ARVO 2025 - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

Wet Age-Related Macular Degeneration Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, NICE Approvals, Prevalence, and Companies by DelveInsight - Barchart.com

Apr 30, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Increases Holdings in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 27, 2025
pulisher
Apr 24, 2025

Kodiak Sciences Inc [KOD] Shares Rise 9.62 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

A year in review: Kodiak Sciences Inc (KOD)’s performance in the last year - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insider’s View: Deciphering Kodiak Sciences Inc (KOD)’s Financial Health Through Ratios - DWinneX

Apr 24, 2025
pulisher
Apr 18, 2025

April 2025's Promising Penny Stocks - Yahoo

Apr 18, 2025
pulisher
Apr 18, 2025

Stealth biotech bags rights to VelaVigo bispecific in $440M deal - Fierce Biotech

Apr 18, 2025
pulisher
Apr 17, 2025

AMKR Shares Experience Decline in Value - knoxdaily.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Kodiak Sciences Inc., Outlook Therapeutics, Eye point Pharmaceuticals - The Globe and Mail

Apr 17, 2025
pulisher
Apr 15, 2025

Why Coffee Prices Remain Volatile - The Globe and Mail

Apr 15, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Sells 65,400 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Wet Age-Related Macular Degeneration Therapeutics Market Size - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Sei Investments Co. Sells 69,599 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 09, 2025
pulisher
Apr 04, 2025

Kodiak Sciences stock hits 52-week low at $2.15 - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Comments on Kodiak Sciences Q2 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

HC Wainwright Forecasts Kodiak Sciences Q1 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Sells 6,758 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Kodiak Sciences Advances Retinal Therapies with Promising Pipeline - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Kodiak Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Kodiak Sciences Inc Azioni (KOD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kodiak Sciences Inc Azioni (KOD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
BORGESON JOHN A.
See Remarks
Jun 12 '24
Sale
2.92
1,558
4,549
179,544
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):